title: Guanabenz-induced inhibition of aldosterone secretion from isolated rat adrenal glomerulosa cells.
abstract: The authors examined the effects of the alpha 2-adrenergic agonist guanabenz and other alpha-adrenergic ligands on aldosterone secretion and cyclic nucleotide content in isolated rat adrenal glomerulosa cells. Guanabenz inhibited aldosterone secretion stimulated by potassium, angiotensin II (AII), and adrenocorticotropic hormone (ACTH), exhibiting IC50 values of 35 microM, 43 microM, and 58 microM for stimulation by 10 mM K+, 1 nM AII, and 10 pM ACTH, respectively. Guanabenz did not affect the cGMP content of purified adrenal glomerulosa cells but inhibited ACTH stimulation of cAMP accumulation. Guanabenz inhibition of ACTH-induced cAMP may represent a mechanism for inhibition of aldosterone secretion, however, guanabenz also inhibited aldosterone secretion stimulated by the cAMP analog dibutyryl cAMP. The effect of guanabenz on the early and late pathways of steroidogenesis was tested in the isolated rat glomerulosa cells using 25-OH cholesterol and steroid precursors to aldosterone. Guanabenz inhibited the steroidogenic response to 25-OH cholesterol stimulation of aldosterone secretion but induced a much smaller inhibition of the steroidogenic response to exogenous pregnenolone, progesterone, and 11-deoxycorticosterone. These results suggested that guanabenz inhibited aldosterone secretion primarily through inhibition of the early component of the steroidogenic pathway prior to pregnenolone formation. The effects of guanabenz were not mimicked by other alpha-adrenergic ligands suggesting that these effects of guanabenz were not mediated through activation of alpha-adrenergic receptors.
authors.affiliation: Department of Medicine, Medical College of Ohio, Toledo 43699-0008.
authors.forename: D P
authors.initials: DP
authors.lastname: Lotshaw
authors.forename: R
authors.initials: R
authors.lastname: Franco-Saenz
authors.forename: P J
authors.initials: PJ
authors.lastname: Mulrow
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000450:Aldosterone / Q000096:biosynthesis / Q000378:metabolism*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism; D005260:Female; D006143:Guanabenz / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D012636:Secretory Rate / Q000187:drug effects; D015384:Zona Glomerulosa / Q000378:metabolism*
chemical_list: D011942:Receptors, Adrenergic, alpha; D000804:Angiotensin II; D000450:Aldosterone; D003994:Bucladesine; D000324:Adrenocorticotropic Hormone; D006143:Guanabenz; D006152:Cyclic GMP